← All stocks

GeoVax Labs, Inc.

GOVX Net buying
CIK 0000832489 #5528 in the set updated 22 Sep 2026
Bought (120 mo)
$1.41M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.41M
+$1.41M against sales at will

By person

8 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
DODD DAVID A
President, CEO
$495.98K (7)
+$495.98K
36,661
$20.16K
Reynolds Mark
CFO
$324.02K (5)
+$324.02K
14,013
$7.70K
MCNALLY ROBERT T
Director
$269.63K (1)
+$269.63K
53,925
$29.65K
SPENCER JOHN N JR
Director
$120.42K (3)
+$120.42K
21,402
$11.77K
CHASE RANDAL D
Director
$106.17K (3)
+$106.17K
36,613
$20.13K
Kollintzas Dean G
Director
$59.94K (1)
+$59.94K
11,987
$6.59K
McKee Kelly T. Jr.
Chief Medical Officer
$23.81K (6)
+$23.81K
3,494
$1.92K
Sharkey John W.
VP, Business Development
$6.76K (2)
+$6.76K
6,191
$3.40K

No percentages here. This company's share count has moved by a factor of 10.3 over the window, from 2,892,570 to 29,705,360 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 111
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 15 Dec 2016